Highlights Eli Lilly and Company Lima

Equities

US5324571083

End-of-day quote Lima Other stock markets 18:00:00 2024-06-27 EDT			5-day change	1st Jan Change
903.6 ^USD	-.--%		+4.82%	-.--%

06-28	Atossa Therapeutics Doubles Z-Endoxifen Dose in Phase 2 Breast Cancer Study	MT
06-28	EMA Says CHMP Gave Positive Opinion For mResvia RSV mRNA Vaccine For Prevention In Adults 60 Years And Older	RE

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Atossa Therapeutics Doubles Z-Endoxifen Dose in Phase 2 Breast Cancer Study	06-28	MT
EMA Says CHMP Gave Positive Opinion For mResvia RSV mRNA Vaccine For Prevention In Adults 60 Years And Older	06-28	RE
India plans incentives for diabetes, obesity drug makers in 2026, government official says	06-28	RE
Eli Lilly Working With OpenAI to Develop Medicines Against Drug-Resistant Pathogens	06-25	DJ
Eli Lilly Teams Up With OpenAI to Develop Antimicrobials for Drug-Resistant Bacteria	06-25	MT
Eli Lilly: collaboration agreement with OpenAI	06-25	CF
Eli Lilly Partners With OpenAI for Developing Antimicrobials to Treat Drug-Resistant Bacteria	06-25	MT
Novo Nordisk's Wegovy Weight-Loss Drug Gets Approval in China	06-25	DJ
Trending : Lilly Anti-Obesity Drug Tirzepatide Reduces Sleep Apnea Severity in Studies	06-24	DJ
Doctors must keep Ozempic prescriptions in check, Danish regulator says	06-24	RE
Eli Lilly Keeps Quarterly Dividend at $1.30 a Share, Payable Sept. 10 to Shareholders of Record on Aug. 15	06-24	MT
Eli Lilly and Company Declares Dividend for the Third Quarter of 2024, Payable on September 10, 2024	06-24	CI
Global markets live: Novo Nordisk, Apple, UPS, Eli Lilly, Qualcomm...	06-24
What other health conditions are weight-loss drugs being tested for?	06-24	RE
Eli Lilly Weight-loss Drug Found to Benefit Obese Adults With Obstructive Sleep Apnea	06-22	MT
Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar	06-21	RE
Eli Lilly and Company Announces Detailed Results from the Surmount-OSA Phase 3 Clinical Trials Evaluating Tirzepatide Injection	06-21	CI
Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says	06-21	RE
Eli Lilly Sues More Wellness Centers, Medical Spas Over Unauthorized Tirzepatide Sales	06-21	MT
Health Care Stocks Rise Behind Gilead -- Health Care Roundup	06-20	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 02:47 pm